Guidelines for the management of Helicobacter pylori infection

PREAMBLE Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data are not available that will withstand objective scrutiny, a recommendation may be made based on a consensus of experts. Guidelines are intended to apply to the clinical situation for all physicians without regard to specialty. Guidelines are intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. Given the wide range of choices in any health care problem, the physician should select the course best suited to the individual patient and the clinical situation presented. These guidelines are developed under the auspices of the American College of Gastroenterology and its practice parameters committee. These guidelines are also approved by the governing boards of the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the American Association for the Study of Liver Diseases. Expert opinion is solicited from the outset for the document. Guidelines are reviewed in depth by the committee, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time. The following guidelines are intended for adults and not for pediatric patients.

[1]  R. Hunt,et al.  Helicobacter pylori : basic mechanisms to clinical cure 2000 : the proceedings of a symposium organised by Axcan Pharma, held in Bermuda, March 26-29, 2000 , 2000 .

[2]  Eddine Mn Gastric malt lymphoma and Helicobacter pylori infection , 1998 .

[3]  R. Hopkins Current FDA-approved treatments for Helicobacter pylori and the FDA approval process. , 1997, Gastroenterology.

[4]  M. Stolte,et al.  What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? , 1997, Gastroenterology.

[5]  R. Cherian,et al.  Prospective, multivariate evaluation of CLOtest performance. , 1997, The American journal of gastroenterology.

[6]  A. Rollán,et al.  Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment. , 1997, The American journal of gastroenterology.

[7]  Jones Db,et al.  Testing for Helicobacter pylori infection after antibiotic treatment. , 1997 .

[8]  E. Furth,et al.  Quantitative breath testing does not predict the presence of peptic ulcer disease. , 1997, Gastrointestinal endoscopy.

[9]  R. Spiller,et al.  Healing of duodenal ulcer after eradication of Helicobacter heilmannii , 1997, The Lancet.

[10]  L. Laine,et al.  Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. , 1997, Gastrointestinal endoscopy.

[11]  A. Blum,et al.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. , 1997, Gastroenterology.

[12]  J. Atherton,et al.  Non‐endoscopic tests in the diagnosis of Helicobacter pylori infection , 1997, Alimentary pharmacology & therapeutics.

[13]  L. Laine,et al.  Endoscopic methods for the diagnosis of Helicobacter pylori , 1997, Alimentary pharmacology & therapeutics.

[14]  A. Axon Chronic dyspepsia: who needs endoscopy? , 1997, Gastroenterology.

[15]  M. Stolte,et al.  Gastric MALT‐lymphoma and Helicobacter pylori infection , 1997, Alimentary pharmacology & therapeutics.

[16]  S. V. Zanten The role of Helicobacter pylori infection in non‐ulcer dyspepsia , 1997 .

[17]  W. Chey,et al.  Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. , 1997, The American journal of gastroenterology.

[18]  B. Dunn,et al.  The Pyloritek test and the CLO test: accuracy and incremental cost analysis. , 1997, The American journal of gastroenterology.

[19]  J. Kleibeuker,et al.  Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori , 1997, Journal of clinical microbiology.

[20]  A. Cutler,et al.  Quantitative noninvasive testing for Helicobacter pylori does not predict gastroduodenal ulcer disease. , 1996, Gastrointestinal endoscopy.

[21]  L. Laine,et al.  Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. , 1996, Gastrointestinal endoscopy.

[22]  D. Graham,et al.  Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. , 1996, The American journal of gastroenterology.

[23]  L. Laine,et al.  Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pylori , 1996, Alimentary pharmacology & therapeutics.

[24]  L. Laine,et al.  The influence of warming on rapid urease test results: a prospective evaluation. , 1996, Gastrointestinal endoscopy.

[25]  R. Logan,et al.  Accuracy of near-patient blood tests for Helicobacter pylori , 1996, The Lancet.

[26]  E. Kuipers,et al.  Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. , 1996, The New England journal of medicine.

[27]  H. Frierson,et al.  Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. , 1996, The American journal of gastroenterology.

[28]  M. Blaser,et al.  Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. , 1995, Gastroenterology.

[29]  M. Stolte,et al.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection , 1995, The Lancet.

[30]  F. Cavalli,et al.  Eradication of Helicobacter pylori Infection in Primary Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue , 1995, Annals of Internal Medicine.

[31]  E. Pérez-Trallero,et al.  Non-endoscopic method to obtain Helicobacter pylori for culture , 1995, The Lancet.

[32]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[33]  A. Wotherspoon,et al.  Helicobacter pylori infection and gastric lymphoma. , 1998, British medical bulletin.

[34]  W. D. de Boer,et al.  Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection. , 1998, The Netherlands journal of medicine.

[35]  D. Jones,et al.  Testing for Helicobacter pylori infection after antibiotic treatment. , 1997, The American journal of gastroenterology.

[36]  M. Stolte,et al.  Clinical presentation, diagnosis and treatment of Helicobacter pylori -related gastric lymphoma , 1996 .

[37]  W. Chey,et al.  Prolonged effect of omeprazole on the 14C-urea breath test. , 1996, The American journal of gastroenterology.

[38]  R. Hunt,et al.  Helicobacter pylori and dyspepsia: a conceptual approach , 1996 .

[39]  F. Mégraud What is the relevance of resistance of Helicobacter pylori to antimicrobial agents , 1996 .

[40]  A. Thomson,et al.  Helicobacter pylori: Basic Mechanisms to Clinical Cure , 1995 .

[41]  An epidemiological study of peptic ulcer disease , 1988 .